Baillie Gifford & CO Abiomed Inc Transaction History

Baillie Gifford & CO

$131 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 24, 2023	SELL	$0.0 - $381.3 $0 - $1.38 Billion	-3,621,946 Reduced 99.92%	2,991 $1.14 Million
Q3 2022 Oct 27, 2022	SELL	$242.49 - $301.46 $20.6 Million - $25.6 Million	-84,884 Reduced 2.29%	3,624,937 $891 Million
Q2 2022 Aug 08, 2022	BUY	$224.73 - $338.64 $128,320 - $193,363	571 Added 0.02%	3,709,821 $918 Million
Q1 2022 May 05, 2022	SELL	$277.25 - $366.29 $36.2 Million - $47.9 Million	-130,730 Reduced 3.4%	3,709,250 $1.23 Billion
Q4 2021 Jan 20, 2022	BUY	$300.63 - $371.35 $31.9 Million - $39.5 Million	106,270 Added 2.85%	3,839,980 $1.38 Billion
Q3 2021 Oct 19, 2021	BUY	$310.19 - $376.2 $31.1 Million - $37.7 Million	100,298 Added 2.76%	3,733,710 $1.22 Billion
Q2 2021 Aug 02, 2021	BUY	$262.71 - $351.17 $50.2 Million - $67.1 Million	191,084 Added 5.55%	3,633,412 $1.13 Billion
Q1 2021 May 06, 2021	BUY	$285.92 - $355.13 $115 Million - $142 Million	400,501 Added 13.17%	3,442,328 $1.1 Billion
Q4 2020 Feb 10, 2021	BUY	$251.88 - $324.2 $24.3 Million - $31.3 Million	96,574 Added 3.28%	3,041,827 $986 Million
Q3 2020 Nov 12, 2020	BUY	$255.22 - $317.0 $25.6 Million - $31.7 Million	100,149 Added 3.52%	2,945,253 $816 Million
Q2 2020 Aug 12, 2020	BUY	$141.4 - $257.09 $16.8 Million - $30.5 Million	118,724 Added 4.35%	2,845,104 $687 Million
Q1 2020 May 08, 2020	BUY	$130.51 - $196.01 $848,184 - $1.27 Million	6,499 Added 0.24%	2,726,380 $396 Million
Q4 2019 Feb 10, 2020	BUY	$159.31 - $223.54 $4.34 Million - $6.09 Million	27,260 Added 1.01%	2,719,881 $464 Million
Q3 2019 Nov 07, 2019	BUY	$175.89 - $279.23 $83.3 Million - $132 Million	473,485 Added 21.34%	2,692,621 $479 Million
Q2 2019 Aug 08, 2019	BUY	$250.96 - $284.94 $286 Million - $324 Million	1,137,705 Added 105.2%	2,219,136 $578 Million
Q1 2019 May 01, 2019	BUY	$276.39 - $362.25 $3.47 Million - $4.55 Million	12,572 Added 1.18%	1,081,431 $0
Q4 2018 Feb 14, 2019	BUY	$281.08 - $444.25 $74.3 Million - $117 Million	264,252 Added 32.84%	1,068,859 $347 Million
Q3 2018 Nov 13, 2018	SELL	$354.53 - $449.75 $461 Million - $585 Million	-1,301,713 Reduced 61.8%	804,607 $362 Million
Q2 2018 Jul 17, 2018	BUY	$278.07 - $446.21 $17.1 Million - $27.4 Million	61,385 Added 3.0%	2,106,320 $862 Million
Q1 2018 May 10, 2018	BUY	$192.49 - $295.85 $18.3 Million - $28.2 Million	95,241 Added 4.88%	2,044,935 $595 Million
Q4 2017 Feb 13, 2018	SELL	$168.78 - $199.74 $4.6 Million - $5.45 Million	-27,267 Reduced 1.38%	1,949,694 $365 Million
Q3 2017 Oct 20, 2017	BUY	$145.39 - $168.6 $766,350 - $888,690	5,271 Added 0.27%	1,976,961 $333 Million
Q2 2017 Aug 10, 2017	BUY	N/A	1,971,690	1,971,690 $283 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account